Skip to Content

Subscribe to Promise

Promise is published four times a year by The University of Texas MD Anderson Cancer Center.

Give now

Your gift to makes a difference in the lives of cancer patients by supporting innovative patient care, research, education and prevention programs.

"Targeting mitochondrial function with drugs called OXPHOS inhibitors to overcome resistance to targeted therapies would be an entirely new paradigm in cancer treatment."

Giulio Draetta, Ph.D., M.D.

professor, Molecular and Cellular Biology and Genomic Medicine

Let's get started. Request an appointment online or call us at 1-877-632-6789. 1-877-632-6789.